Género, biomedicina y el virus del papiloma humano en México. Algunas complejidades sociotécnicas en la política pública de vacunación

INTRODUCTION. The Human Papillomavirus (HPV) preventive vaccine emerged in 2000’s first decade as a biomedical alternative to decrease cervical cases rates, that represent one of the leading death causes among young women in Latin America and other countries that face inequalities. OBJECTIVE. To ana... View More